Related Experiment Videos

Chloroquine inhibits macrophage tumour necrosis factor-alpha mRNA transcription

X Zhu1, W Ertel, A Ayala

  • 1Department of Surgery, Michigan State University, East Lansing 48824-1315.

Immunology
|September 1, 1993
PubMed

Insights

Chloroquine significantly reduces tumor necrosis factor-alpha (TNF-alpha) release from macrophages. This occurs by inhibiting TNF-alpha gene transcription, not mRNA stability, following hemorrhage.

Area of Science:

  • Immunology
  • Pharmacology
  • Molecular Biology

Background:

  • Hemorrhage can lead to increased inflammatory responses.
  • Macrophages (M phi) are key immune cells involved in inflammation.
  • Tumor necrosis factor-alpha (TNF-alpha) is a critical pro-inflammatory cytokine.

Purpose of the Study:

  • To elucidate the mechanism by which chloroquine reduces TNF-alpha release from macrophages post-hemorrhage.
  • To investigate the effect of chloroquine on TNF-alpha gene transcription and mRNA stability.

Main Methods:

  • Isolation of peritoneal macrophages (pM phi) from mice under different conditions (unmanipulated, sham-operated, post-hemorrhage).
  • In vitro treatment of macrophages with chloroquine followed by lipopolysaccharide (LPS) stimulation.
  • Bioassay to measure TNF-alpha release and Northern blot analysis to assess TNF-alpha mRNA expression and stability.

Main Results:

  • Chloroquine pretreatment inhibited TNF-alpha release by 75-90% in macrophages from all experimental groups.
  • Chloroquine treatment suppressed TNF-alpha mRNA expression.
  • Chloroquine did not affect the stability of TNF-alpha mRNA.

Conclusions:

  • Chloroquine reduces macrophage-mediated TNF-alpha release by inhibiting TNF-alpha gene transcription.
  • This mechanism is effective in macrophages from both normal and post-hemorrhage states.
  • Findings suggest a novel therapeutic target for managing inflammation associated with hemorrhage.

Related Concept Videos